OR WAIT null SECS
July 06, 2021
An updated version of legislation to modernize clinical research policies and FDA expedited approval pathways is circulating on Capitol Hill.
June 30, 2021
Chalmers University researchers have developed a method to label and track mRNA molecules.
The Cell and Gene Therapy Catapult will establish offices and laboratories in Edinburgh, Scotland.
Evonik has released an innovative green technology that can enable the large-scale synthesis of APIs in water.
Pharmapack Europe event organizers have revealed increased levels of innovation in drug delivery across the industry, substantiated by the level of regulatory approvals.
June 29, 2021
The Council of Europe has appointed Petra Dörr, PhD, as the future director of the European Directorate for the Quality of Medicines and Healthcare (EDQM).
Otsuka Pharmaceuticals Europe has filed an initial marketing authorization application to the European Medicines Agency for voclosporin.
June 24, 2021
The University of Birmingham has been confirmed as the third National Training Centre in the Advanced Therapies Skills Training Network (ATSTN) initiative
June 22, 2021
FDA's CDER has launched an initiative to gain more efficient and transparent operations of its advisory panels.
June 21, 2021
The final guidance document is intended to help determine which reporting category is appropriate for a change in CMC information to an approved biologics application.